BIOMARKER

The present invention relates to a novel method for detecting zearalenone (ZEN) effect comprising determining the expression level of at least one miRNA in a test sample, as well as to a novel use of at least one miRNA for detecting zearalenone (ZEN) effect in a test sample. La présente invention co...

Full description

Saved in:
Bibliographic Details
Main Authors NAGL, Veronika, BINDER, Eva-Maria, SCHATZMAYR, Gerd, GRENIER, Bertrand
Format Patent
LanguageEnglish
French
Published 11.06.2020
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel method for detecting zearalenone (ZEN) effect comprising determining the expression level of at least one miRNA in a test sample, as well as to a novel use of at least one miRNA for detecting zearalenone (ZEN) effect in a test sample. La présente invention concerne un nouveau procédé de détection d'un Effet de zaralénone (ZEN) comprenant la détermination du niveau d'expression d'au moins un miARN dans un échantillon d'essai, ainsi qu'une nouvelle utilisation d'au moins un miARN pour détecter un effet de zaralénone (ZEN) dans un échantillon d'essai.
Bibliography:Application Number: WO2019EP83953